Menta Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,023
Closed -$311K 611
2018
Q3
$311K Sell
8,023
-1,066
-12% -$38.4K 0.11% 368
2018
Q2
$304K Sell
9,089
-11,180
-55% -$398K 0.07% 468
2018
Q1
$734K Sell
20,269
-782
-4% -$27.1K 0.16% 250
2017
Q4
$670K Buy
21,051
+4,700
+29% +$161K 0.13% 289
2017
Q3
$612K Sell
16,351
-21,741
-57% -$740K 0.09% 406
2017
Q2
$1.19M Sell
38,092
-8,794
-19% -$254K 0.14% 260
2017
Q1
$1.16M Buy
46,886
+20,231
+76% +$475K 0.11% 307
2016
Q4
$675K Sell
26,655
-6,700
-20% -$149K 0.06% 554
2016
Q3
$662K Buy
33,355
+14,474
+77% +$253K 0.06% 492
2016
Q2
$269K Buy
+18,881
New +$289K 0.04% 716

Other funds holding LMAT

Menta Capital's LMAT Position: Q4 2018 in Review

Menta Capital sold out of LeMaitre Vascular (LMAT) in Q4 2018, closing a stake of 8,023 shares — an estimated $311K sold.

Menta Capital first reported a position in LMAT in Q2 2016 and held it in 10 quarters. The position peaked at $1.19M in Q2 2017. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

  • Menta Capital reported no remaining LeMaitre Vascular position as of Q4 2018 after selling out during the quarter.
  • Menta Capital sold 8,023 LeMaitre Vascular shares in Q4 2018, an estimated $311K.
  • Menta Capital first reported a position in LeMaitre Vascular in Q2 2016 and held it in 10 quarters.
  • Menta Capital's LeMaitre Vascular position peaked at $1.19M in Q2 2017.
  • 139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Menta Capital's 13F filing for Q4 2018, filed 14 Feb 2019.